Peptides

Peptides are crucial for various physiological processes and are vital in many biochemical reactions. These short chains of 2 to 50 amino acids are formed through a condensation reaction, creating covalent bonds that link the amino acids together. As more amino acids join through sequential covalent bonds, they form a peptide chain, the fundamental building block of proteins. New studies suggest that certain types of peptides may be beneficial in slowing down the aging process, decreasing inflammation, and combating microbes.

Mind Body Neurology® offers integrated neurology services in Minneapolis to determine how peptides could be added to new or existing therapies to improve outcomes for neurological conditions.

Peptides are often mistaken for proteins. While both are composed of amino acids, peptides contain fewer amino acids than proteins. Similar to proteins, peptides are naturally found in various foods. Peptides have the potential to address the underlying factors of neurodegenerative diseases through multiple mechanisms.

One such mechanism involves their ability to reduce inflammation, a key factor contributing to neurodegeneration. Many peptides possess anti-inflammatory properties that can inhibit the activation of immune cells responsible for promoting inflammation. As a result, peptides may play a role in reducing neuroinflammation and preventing neuronal cell death.

Peptides can reduce neurodegeneration by supporting neuron growth and survival. They can also boost the production of nerve growth factors, which play a crucial role in neuron development and upkeep. Damaged neurons may also receive assistance in regenerating and forming new synapses, which play a vital role in brain function.

Peptide treatment has demonstrated promising results in the management of several neurodegenerative diseases. Here are a few examples.

Alzheimer’s disease is identified by the buildup of amyloid-beta, a protein that creates plaques in the brain and is linked to the disease. Research indicates that specific peptides can potentially prevent amyloid-beta accumulation and inhibit enzymes from degrading acetylcholine, a crucial neurotransmitter for memory and learning.

Parkinson’s disease results from the deterioration of nerve cells responsible for producing dopamine, a neurotransmitter generated in the substantia nigra region of the brain. Research has indicated that peptides can enhance dopamine production and shield dopaminergic neurons from harm.

Huntington's disease results from an abnormal increase in a trinucleotide repeat within the huntingtin gene. This leads to the accumulation of mutant huntingtin protein and subsequent neuronal death. Peptides have shown promise in inhibiting the aggregation of mutant huntingtin proteins and minimizing neuronal loss.

Amyotrophic Lateral Sclerosis (ALS) involves the degeneration of motor neurons in the brain and spinal cord. Peptides have shown potential in promoting the growth and survival of motor neurons while also inhibiting the toxicity of mutant proteins linked to the disease.

Peptides have shown promise in the treatment of neurodegenerative diseases, although they may not be effective as a standalone treatment. Combining peptides with other therapies could offer a more comprehensive and effective approach.

There are various methods for combining peptides with other therapies. Peptide-based therapies can be utilized in conjunction with existing drugs. Recent research has indicated that a combination of a peptide promoting the growth of dopaminergic neurons and a drug that accelerates dopamine release improved the symptoms of Parkinson's disease. This innovative approach to therapy has the potential to enhance the treatment of neurodegenerative diseases.

Do you or someone close to you suffer from troubling neurological conditions? Alexander Y. Zubkov, M.D., PhD, and his team at Mind Body Neurology® in Minneapolis may be able to combine advanced peptide therapy with new or existing treatments to achieve more optimal results. Contact us to schedule your consultation and learn more about the potential of peptide therapy.